[{"orgOrder":0,"company":"Anklam Extrakt GmbH","sponsor":"Anklam Extrakt GmbH","pharmaFlowCategory":"DU","therapeuticArea":"Undisclosed","country":"U.S.A","productType":"Plant Extract\/Herbal","year":"2025","type":"Inapplicable","leadProduct":"Maqui Berry Standardized Extract","moa":"Undisclosed","graph1":"Undisclosed","graph2":"Undisclosed","graph3":"Anklam Extrakt GmbH","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"","amount2New":0,"dosageForm":"Powder","sponsorNew":"Anklam Extrakt GmbH \/ Anklam Extrakt GmbH","highestDevelopmentStatusID":"1","companyTruncated":"Anklam Extrakt GmbH \/ Anklam Extrakt GmbH"}]

Find Clinical Drug Pipeline Developments & Deals by Anklam Extrakt GmbH

Menu
Xls
Filters Filter
×
FILTER:
filter
Company Name
    filter

    Year

      filter

      DEALS // DEV.

        filter

        Country

          filter
          Sponsor
            filter

            Therapeutic Area

              filter

              Study Phase

                filter

                Deal Type

                  filter

                  Product Type

                    filter

                    Dosage Form

                      filter

                      Lead Product

                        filter

                        Target

                          Loading...

                          Therapeutic Area by Lead Product

                          Study Phase by Lead Product

                          Company by Lead Product

                          Top Deals by Deal Size (USD bn)

                          01

                          FNCE
                          Not Confirmed
                          FNCE
                          Not Confirmed

                          Details : Delphinol (Maqui Berry Standardized Extract) is a Plant Extract/Herbal drug candidate, which is currently being evaluated in Undisclosed clinical studies for the treatment of undefined medical condition.

                          Product Name : Delphinol

                          Product Type : Plant Extract/Herbal

                          Upfront Cash : Inapplicable

                          September 29, 2025

                          Lead Product(s) : Maqui Berry Standardized Extract

                          Therapeutic Area : Undisclosed

                          Highest Development Status : Undisclosed

                          Recipient : University of Memphis

                          Deal Size : Inapplicable

                          Deal Type : Inapplicable

                          blank